Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Changing mortality in dilated cardiomyopathy
1994
The Role of the Autonomic Nervous System in Sudden Cardiac Death
2008
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
1997 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Hemodynamic improvement and removal of autoantibodies against β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy
2003
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Passive epicardial containment prevents ventricular remodeling in heart failure
2000
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
1999 StandoutNobel
The Role of Echocardiography in the Diagnosis and Management of Heart Failure
2003
Autoimmunity in Myocarditis: Relevance of Animal Models
1997
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
2003
The development of allergic inflammation
2008 StandoutNature
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Monogenic mineralocorticoid hypertension
2006
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure
1990
Myocarditis
2000 Standout
The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.
1998
Iron deficiency is common in idiopathic pulmonary arterial hypertension
2010
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trial
1994
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
1993
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
1993
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Biomarkers in Heart Failure
2008 Standout
Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study
2006
Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT)
1993
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance
2002
Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction
1999
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Chrousos syndrome: from molecular pathogenesis to therapeutic management
2015
Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
1995
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Pharmacogenetics and asthma: false hope or new dawn?: Table 1—
2007
Controlling signaling with a specifically designed G i -coupled receptor
1998
IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease
1999
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac G sα Overexpression
1996
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
2000 StandoutNobel
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
The Role of ??-Blockers in the Treatment of Cardiomyopathy and Ischaemic Heart Failure
1994
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
1999
Prognostic Value of Bisoprolol-Induced Hemodynamic Effects in Heart Failure During the Cardiac Insufficiency BIsoprolol Study (CIBIS)
1997
Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution
2001
Agonistic Anti-β1-Adrenergic Receptor Autoantibodies From Cardiomyopathy Patients Reduce the β1-Adrenergic Receptor Expression in Neonatal Rat Cardiomyocytes
1998
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Secondary Pulmonary Hypertension in Chronic Heart Failure
2000
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Works of C.‐H. Bergh being referenced
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
2009
A mutation of the glucocorticoid receptor in primary cortisol resistance.
1993
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
1993
Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action.
1993
Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
1989
Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
1994